about
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents.Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1)Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1H-ImidazoleNew more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1.HLA Class II Antibody Activation of Endothelial Cells Promotes Th17 and Disrupts Regulatory T Lymphocyte Expansion.TP-0903 inhibits neuroblastoma cell growth and enhances the sensitivity to conventional chemotherapy.AKR1C enzymes sustain therapy resistance in paediatric T-ALL.Choline Kinase Alpha Inhibition by EB-3D Triggers Cellular Senescence, Reduces Tumor Growth and Metastatic Dissemination in Breast CancerEB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cellsLead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitorsPotent In Vitro and In Vivo Anticancer Activity of New Bipyridine and Bipyrimidine Gold (III) Dithiocarbamate Derivatives.A BAG's life: Every connection matters in cancerDesign, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2- d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule InhibitorsSYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric ETV6-RUNX1 B-Acute Lymphoblastic Leukemia PatientsDesign, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors
P50
Q33560133-5026958B-6689-4C0D-A0DB-C0C62E909087Q36748138-68576F9C-7EFF-426C-84D9-000384955B95Q36928505-BC791B4C-2EEC-4F34-B04F-AD633F89904DQ39017908-27840AB9-7D88-494A-9C11-DEA414142B96Q40266578-15D0A10A-DB6D-43E7-ABC4-FD8914F21DC2Q49866304-B4012918-4911-4EF4-82E6-7AC02C2D11AFQ53703893-7355A440-4ADD-48AD-9878-461E6DFE7FE9Q58579238-86D3C77D-B50F-4038-B96E-C64C72FF6B31Q61543574-71DEA893-DC38-4572-B155-01E3FFB3F792Q61543582-AB90D59E-8B66-4083-B1B7-00CF06924917Q64917014-9ACD4280-4223-40F7-B01A-DEFEDBA14C95Q89452275-8D6951CE-F857-4140-BCA0-B528008456ACQ91001114-08F58BAB-7419-4F1E-AC64-3EDB89229A1DQ91815931-29C548B1-8DDD-4B52-8220-7EAEFD975B70Q92541759-B82F9AF3-8421-4596-A075-A277A85BFA91
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Elena Mariotto
@ast
Elena Mariotto
@en
Elena Mariotto
@es
Elena Mariotto
@nl
Elena Mariotto
@sl
type
label
Elena Mariotto
@ast
Elena Mariotto
@en
Elena Mariotto
@es
Elena Mariotto
@nl
Elena Mariotto
@sl
prefLabel
Elena Mariotto
@ast
Elena Mariotto
@en
Elena Mariotto
@es
Elena Mariotto
@nl
Elena Mariotto
@sl
P106
P21
P31
P496
0000-0002-3960-8561